Top section
Top section
Meanwhile, LatAm sovereign announces mandate for a multi-tranche deal that could come next week
Sovereign closed 'remarkable' deal despite US Treasury pricing drama
Big, volatile week in EM raises questions around fair values
Data
More articles
More articles
More articles
-
Shanghai Junshi Biosciences has raised HK$3.08bn ($394.2m) after pricing its IPO at the bottom of the range, according to a banker on the deal. -
Bank of Jinzhou is planning to raise HK$8.22bn ($1.05bn) through a private placement of H-shares, according to a filing with the Hong Kong Stock Exchange.
-
Regulators agreed to impose a tighter identification regime for southbound trading of Stock Connect, foreign direct investment (FDI) into China dropped for the third month, and the Ministry of Finance (MoF) confirmed temporary import tariff cuts for automobiles from the US.
-
Philippine Savings Bank wants to raise Ps8bn ($150.84m) from a rights issue early next year, fixing the price of the offering at Ps56 apiece.
-
Citi is pulling out of its China securities joint venture. It gave its partner notice at the end of last week.
-
Equate Group, the Kuwaiti petrochemical producer, has amended and extended its $1.9bn term loan and $1bn revolving credit facility, achieving a reduction in pricing and strong demand from international lenders.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
